MCK

McKesson Corporation

Healthcare
736.78 +1.96 +0.27% Market Closed
2026-06-02 • USD

Key Metrics

Market Cap 88.56B
EV —
Shares Out 120.20M
Revenue (ttm) 403.43B
Net Income 4.76B
Beta —
P/E 19.12
Forward P/E —
EPS (ttm) $38.38
P/S 0.23
P/B -41.93
P/FCF —
P/C —
EV/Sales —
EV/EBITDA —
ROA 5.78%
ROE -219.24%
ROIC 66.26%
Gross Margin 3.61%
Oper. Margin 1.54%
Profit Margin 1.18%
Debt/Eq -4.55
LT Debt/Eq 149.89%
Quick Ratio —
Current Ratio 0.85
Book/sh -17.57
Cash/sh 32.16
Div Yield 0.43%
Div TTM $3.17
Payout Ratio 8.26%
SMA20 -2.07%
SMA50 -9.39%
SMA200 -10.03%
Volume 885,434
Avg Volume 954.95K
Rel Volume —
Perf Week -2.67%
Perf Month -8.80%
Perf Quarter -24.72%
Perf Half Y -9.51%
Perf YTD -10.18%
Perf Year 3.85%
Perf 3Y 88.84%
Perf 5Y 277.95%

Factor Lens

Seasonal Performance

Dividends

Per-share amounts adjusted for stock splits.

Last Dividend $0.8200
TTM Yield 0.43%
TTM Amount $3.17
Payout Ratio 8.26%
3-Yr Growth (CAGR) 14.90%
5-Yr Growth (CAGR) 8.79%

Last 12 Payouts

Period Ex-Date Amount / Share
Q4 2025 ~2026-04-01 $0.8200
Q3 2025 ~2025-12-31 $0.8200
Q2 2025 ~2025-09-30 $0.8200
Q1 2025 ~2025-06-30 $0.7100
Q4 2024 ~2025-04-01 $0.7100
Q3 2024 ~2024-12-31 $0.7100
Q2 2024 ~2024-09-30 $0.7100
Q1 2024 ~2024-06-30 $0.6200
Q4 2023 ~2024-03-31 $0.6200
Q3 2023 ~2023-12-31 $0.6200
Q2 2023 ~2023-09-30 $0.6200
Q1 2023 ~2023-06-30 $0.5400

Financial Trends

Revenue & Net Income

Earnings Per Share

Margins

Cash Flow

Company Overview

McKesson Corporation, incorporated in Delaware in 1994 and tracing its business roots to 1833, is a diversified healthcare services leader dedicated to advancing health outcomes for patients everywhere. The Company operates through multiple business segments: North American Pharmaceutical (distributes branded and generic pharmaceutical products and provides value-added solutions and services), Oncology & Multispecialty (provides oncology and multispecialty pharmaceutical distribution and services), Prescription Technology Solutions (provides software solutions and services to retail and institutional pharmacies), and Medical-Surgical Solutions (distributes medical and surgical supplies and equipment). The Company partners with biopharma companies, care providers, pharmacies, manufacturers, governments, and others to deliver insights, products, and services to help make quality care more accessible and affordable. McKesson's teams deliver pharmaceutical and medical-surgical products and solutions to hospitals, health systems, pharmacies, manufacturers, and other customers, leveraging its scale, distribution expertise, and integrated platforms to support the healthcare ecosystem.

Name
McKesson Corporation
Industry
Medical Distribution
CEO
Brian S. Tyler · Chief Executive Officer
Employees
—
IPO Date
2015-06-01
Phone
(972) 446-4800
Address
6555 State Highway 161, Irving, TX 75039
Website
www.mckesson.com

Key Executives

Name Title FY Pay
Lynne M. Doughtie Retired Chair and Chief Executive Officer, KPMG U.S. —
Bradley E. Lerman Executive Vice President and Chief Legal Officer, Starbucks Corporation —
Donald R. Knauss Retired Chairman and Chief Executive Officer, The Clorox Company —
Dominic J. Caruso Retired Executive Vice President and Chief Financial Officer, Johnson & Johnson —
Brian S. Tyler Chief Executive Officer —

Latest News